Vermeire S - Search Results

1

Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.

Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, Stokkers P, Hommes D, Rutgeerts P, Vermeire S, D'Haens G; Belgian Inflammatory Bowel Disease Research Group; North-Holland Gut Club. Baert F, et al. Among authors: vermeire s. Gastroenterology. 2010 Feb;138(2):463-8; quiz e10-1. doi: 10.1053/j.gastro.2009.09.056. Epub 2009 Oct 8. Gastroenterology. 2010. PMID: 19818785

2

Clustering of increased small intestinal permeability in families with Crohn's disease.

Peeters M, Geypens B, Claus D, Nevens H, Ghoos Y, Verbeke G, Baert F, Vermeire S, Vlietinck R, Rutgeerts P. Peeters M, et al. Among authors: vermeire s. Gastroenterology. 1997 Sep;113(3):802-7. doi: 10.1016/s0016-5085(97)70174-4. Gastroenterology. 1997. PMID: 9287971

3

[Drug prevention of Crohn disease recurrence in the neo-terminal ileum after ileocolic resection].

Vermeire S, Rutgeerts P. Vermeire S, et al. Zentralbl Chir. 1998;123(4):352-6. Zentralbl Chir. 1998. PMID: 9622893 Review. German.

4

Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease.

Rutgeerts P, Vermeire S. Rutgeerts P, et al. Among authors: vermeire s. Gastroenterology. 1998 Oct;115(4):1006-9. doi: 10.1016/s0016-5085(98)70274-4. Gastroenterology. 1998. PMID: 9786723 Review. No abstract available.

5

Diagnostic approach to IBD.

Vermeire S, Peeters M, Rutgeerts P. Vermeire S, et al. Hepatogastroenterology. 2000 Jan-Feb;47(31):44-8. Hepatogastroenterology. 2000. PMID: 10690584 Review.

6

Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity.

Vermeire S, Peeters M, Vlietinck R, Parkes M, Satsangi J, Jewell D, Rutgeerts P. Vermeire S, et al. Inflamm Bowel Dis. 2000 Aug;6(3):165-70. doi: 10.1097/00054725-200008000-00002. Inflamm Bowel Dis. 2000. PMID: 10961588

7

Serological diagnosis of inflammatory bowel disease.

Rutgeerts P, Vermeire S. Rutgeerts P, et al. Among authors: vermeire s. Lancet. 2000 Dec 23-30;356(9248):2117-8. doi: 10.1016/s0140-6736(00)03488-7. Lancet. 2000. PMID: 11191535 No abstract available.

8

Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease.

Vermeire S, Joossens S, Peeters M, Monsuur F, Marien G, Bossuyt X, Groenen P, Vlietinck R, Rutgeerts P. Vermeire S, et al. Gastroenterology. 2001 Mar;120(4):827-33. doi: 10.1053/gast.2001.22546. Gastroenterology. 2001. PMID: 11231936

9

Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome.

Vermeire S, Satsangi J, Peeters M, Parkes M, Jewell DP, Vlietinck R, Rutgeerts P. Vermeire S, et al. Gastroenterology. 2001 Mar;120(4):834-40. doi: 10.1053/gast.2001.22453. Gastroenterology. 2001. PMID: 11231937

10

Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.

Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Peeters M, et al. Among authors: vermeire s. Am J Gastroenterol. 2001 Mar;96(3):730-4. doi: 10.1111/j.1572-0241.2001.03613.x. Am J Gastroenterol. 2001. PMID: 11280542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

859 results

Search Page